| |
| |
|
| Insider
Information: |
Richard John P |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
23,716 |
|
|
Indirect Shares
|
7,500 |
|
|
| Direct
Value |
$18,300 |
|
|
|
Indirect Value
|
$3,835 |
|
|
| Total
Shares |
31,216 |
|
|
| Total
Value |
$22,135 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 38.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gyre Therapeutics |
GYRE |
Director |
2020-03-13 |
3,716 |
2014-12-11 |
7,500 |
Premium* |
|
|
Vaxart Inc |
VXRT |
Director |
2019-10-11 |
20,000 |
2019-10-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
17 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2020-03-13 |
4 |
B |
$3.98 |
$9,950 |
D/D |
2,500 |
3,716 |
2.39 |
% |
|
| VXRT |
Vaxart Inc |
Director |
• • – |
2019-10-11 |
4 |
B |
$0.38 |
$7,680 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2019-05-24 |
4 |
B |
$8.03 |
$8,030 |
D/D |
1,000 |
1,216 |
2.39 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2014-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
15,333 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2012-06-08 |
4 |
B |
$4.16 |
$31,193 |
I/I |
7,500 |
7,500 |
2.1 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-07-01 |
4 |
S |
$21.02 |
$52,550 |
D/D |
(2,500) |
5,333 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-07-01 |
4 |
OE |
$9.27 |
$23,175 |
D/D |
2,500 |
7,833 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-04-01 |
4 |
S |
$26.60 |
$66,500 |
D/D |
(2,500) |
5,333 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-04-01 |
4 |
OE |
$9.27 |
$23,175 |
D/D |
2,500 |
7,833 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-01-19 |
4 |
S |
$27.11 |
$135,543 |
D/D |
(5,000) |
5,333 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-01-19 |
4 |
OE |
$2.71 |
$13,550 |
D/D |
5,000 |
10,333 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-01-18 |
4 |
S |
$27.38 |
$68,440 |
D/D |
(2,500) |
5,333 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-01-18 |
4 |
OE |
$2.71 |
$6,775 |
D/D |
2,500 |
7,833 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-05-14 |
4 |
S |
$24.22 |
$205,863 |
D/D |
(8,500) |
5,333 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-05-14 |
4 |
OE |
$0.08 |
$53,325 |
D/D |
8,500 |
13,833 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2007-02-01 |
4 |
OE |
$0.08 |
$75 |
D/D |
1,000 |
5,333 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2006-04-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,333 |
|
- |
|
17 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
